Immediate Impact
1 from Science/Nature 51 standout
Citing Papers
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Polycystic ovary syndrome
2024 Standout
Works of V. Chaussade being referenced
Sex‐ and age‐adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the « OBJECTIFS PEAU » study
2018
Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| V. Chaussade | 209 | 139 | 90 | 301 | 145 | 23 | 693 | |
| Claire Deloche | 159 | 38 | 115 | 303 | 190 | 12 | 788 | |
| J.M. Villette | 58 | 66 | 74 | 260 | 83 | 29 | 738 | |
| Gerald S. Kidd | 51 | 74 | 99 | 439 | 114 | 32 | 807 | |
| Zaven H. Chakmakjian | 92 | 30 | 46 | 238 | 77 | 20 | 582 | |
| George Kanakis | 46 | 169 | 146 | 195 | 95 | 30 | 609 | |
| Kelly S. Persons | 80 | 41 | 115 | 104 | 120 | 27 | 799 | |
| Li Zeng | 62 | 120 | 18 | 120 | 64 | 36 | 588 | |
| Pietro Affinito | 96 | 29 | 56 | 113 | 89 | 26 | 696 | |
| M Rieu | 36 | 66 | 39 | 444 | 67 | 35 | 588 | |
| Rolf Michael Klein | 44 | 61 | 44 | 76 | 87 | 23 | 602 |
All Works
Loading papers...